Volume 8, Issue 3, March 2015, Pages 185–190
Open Access
Document heading
Depressant effects of Agastache mexicana methanol extract and one of major metabolites tilianin
- Open Access funded by Hainan Medical College
- Under a Creative Commons license
Abstract
Objective
To
determine the depressant–like effects and the possible mechanism of
action of tilianin isolated from active methanol extract of Agastache mexicana (A. mexicana). Also, to establish the pharmacophoric requirements of tilianin, as a possible ligand of GABAA/BZD receptor, by the alignment of diazepam, CGS–9896 and diindole, using a previously described pharmacophoric model.
Methods
Tilianin (30 to 300 mg/kg, ip. and 300 mg/kg, po.) and methanol crude extract (10 to 300 mg/kg, ip. and 300 mg/kg po.) from A. mexicana
were evaluated for potential sedative and anxiolytic–like response
drugs by using open–field, hole–board, cylinder of exploration,
plus–maze and sodium pentobarbital–induced hypnosis mice methods.
Results
Methanol extract and tilianin showed anxiolytic–like activity from a dosage of 30 mg/kg, ip. or 300 mg/kg, po.
and were less potent than diazepam 0.1 mg/kg, a reference anxiolytic
drug used. Moreover, depressant activity of both potentiates sodium
pentobarbital (SP)–induced sleeping time. The anxiolytic–like effect of
30 mg/kg ip. observed for the extract and tilianin, by using
the plus–maze model, was partially prevented in the presence of
flumazenil (a GABAA/BZD antagonist, 5 mg/kg ip.) but not in the presence of WAY 100635 (a selective 5–HT1A receptor antagonist, 0.32 mg/kg, ip.). Pharmacophoric modeling alignments of three agonist of GABAA/BZD allow identify seven chemical features. Tilianin contains six of the seven features previously determined.
Conclusions
Results indicate that tilianin is one of the bioactive metabolites in the anxiolytic–like activity of A. mexicana, reinforcing its central nervous system uses, where GABAA/BZD, but not 5–HT1A, receptors are partially involved.
Keywords
- Agastache mexicana;
- Anxiety;
- Benzodiazepine;
- Central nervous system;
- Sedative;
- Tilianin
References
- 1
- Taxonomy of Agastache section Brittonastrum (Lamiaceae Nepeteae)
- Systematic Botany Monographs, 15 (1987), pp. 1–92
- | |
- 2
- Etnobotany, leaf architecture, and vegetative anatomy of Agastache mexicana ssp. mexicana and A. mexicana ssp. xolocotziana
- Rev Mex Biodivers, 79 (2008), pp. 513–524
- 3
- Atlas of plants from Mexican traditional medicine, Vol. IIIIndigenous National Institute, Mexico (1994), pp. 1355–1356
- |
- 4
- Selection of medicinal plants of MexicoLimusa, Mexico (1988), pp. 1–125
- |
- 5
- Medicinal plants of Mexico: uses and traditional remedies (2nd edition)Electronic and Computer Technology Center and Biology Institute at the National Autonomous University of Mexico, Mexico (1995), pp. 1–155
- |
- 6
- Plantas Medicinales Utilizadas en el Estado de Morelos (2nd edition)Universidad Autónoma del Estado de Morelos (2007)
- 7
- Ethno–Pharmacology in Latin America, an alternative to the globalization of the practices of cure
- Cuadernos Geográficos, 41 (2007), pp. 61–95
- |
- 8
- Agastache mexicana may produce anxiogenic–like actions in the male rat
- Phytomedicine, 7 (2000), pp. 199–203
- | | |
- 9
- Central nervous system effects and chemical composition of two subspecies of Agastache mexicana; an ethnomedicine of Mexico
- J Ethnopharmacol, 153 (2014), pp. 98–110
- | | |
- 10
- Antihypertensive and vasorelaxant effects of tilianin isolated from Agastache mexicana are mediated by NO/cGMP pathway and potassium channel opening
- Biochem Pharmacol, 78 (2009), pp. 54–61
- | | |
- 11
- Vasoactive and antioxidant activities of plants used in Mexican traditional medicine for the treatment of cardiovascular diseases
- Pharm Biol, 48 (2010), pp. 732–739
- | |
- 12
- Antinociceptive and anti–inflammatory activities of the Agastache mexicana extracts by using several experimental models in rodents
- J Ethnopharmacol, 142 (2012), pp. 700–705
- 13
- Comparative chemical composition of Agastache mexicana subsp. mexicana and A. mexicana subsp. xolocotziana
- Biochem Syst Ecol, 32 (2004), pp. 685–694
- | | |
- 14
- Validated liquid chromatographic method and analysis of content of tilianin on several extracts obtained from Agastache mexicana and its correlation with vasorelaxant effect
- J Ethnopharmacol, 138 (2011), pp. 487–491
- | | |
- 15
- Palmitone isolated from Annona diversifolia induces an anxiolytic–like effect in mice
- Planta Med, 72 (2006), pp. 703–707
- | |
- 16
- Exploratory behaviour in chronic disulfotan poisoning in mice
- Psychopharmacologia, 20 (1997), pp. 169–171
- 17
- Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice
- J Pharm Pharmacol, 57 (2005), pp. 631–640
- 18
- The use of a plus–maze to measure anxiety in the mouse
- Psychopharmacol, 92 (1987), pp. 180–185
- |
- 19
- Some pharmacological effects of the ethanol extract of leaves of Annona diversifolia on the central nervous system in mice
- Phytother Res, 2 (1998), pp. 600–602
- | |
- 20
- Hypnotic effects and GABAergic mechanism of licorice (Glycyrrhiza glabra) ethanol extract and its major flavonoid constituent glabrol
- Bioorg Med Chem, 20 (2012), pp. 3493–3501
- | | |
- 21
- Assessment of luteolin (3’, 4’, 5, 7–tetrahydroxyflavone) neuropharmacological activity
- Behav Brain Res, 189 (2008), pp. 75–82
- | | |
- 22
- Investigation of the anxiolytic effects of luteolin, a lemon balm flavonoid in the male Sprague–Dawley rat
- AANA J, 77 (2009), pp. 33–36
- |
- 23
- The contribution of behavioral studies to the neuropharmacology of anxiety
- Neuropharmacology, 26 (1987), pp. 877–886
- | | |
- 24
- Spasmolytic and antinociceptive activities of ursolic acid and acacetin identified in Agastache mexicana
- Planta Med, 78 (2012), pp. 793–796
- 25
- The natural products magnolol and honokiol are positive allosteric modulators of both syn aptic and extra–synaptic GABA(A) receptors
- Neuropharmacology, 62 (2012), pp. 2507–2514
- | | |
- 26
- Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders
- Adv Biochem Psychopharmacol, 47 (1992), pp. 379–394
- |
- 27
- GABAergic modulation of benzodiazepine binding site sensitivity
- Nature, 274 (1978), pp. 383–385
- | |
- 28
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- J Med Chem, 31 (1988), pp. 2235–2246
- | |
- 29
- Flavonoids: a review of probable mechanisms of action and potential applications
- Am J Clin Nutr, 74 (2001), pp. 418–425
- |
Copyright © 2015 Hainan Medical College. Published by Elsevier (Singapore) Pte Ltd.
